MoneyWorks4Me

NGL Fine-Chem informs about credit rating

13 Mar 2026 Evaluate

Pursuant to Regulation 30 read with Schedule III of the SEBI Listing Obligations and Disclosure Requirements), Regulations, 2015, NGL Fine-Chem has informed that, Crisil Ratings vide their letter dated March 12, 2026 has revised its outlook on the long-term bank loan facilities of the Company to ‘Stable’ from ‘Negative’ while reaffirming the rating at ‘Crisil BBB+’. The Short term rating has been reaffirmed at 'Crisil A2'.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..